The Reply

We thank Ishibashi and their colleagues for their interest in our recent publication on the use of the HEAR score and high-sensitivity troponin T assay for risk stratification of emergency department patients presenting with suspected acute coronary syndrome.1 It provides us with an opportunity to make the goal of our study clear. Our work sought to apply the recommendation from the 2021 AHA/ACC chest pain guidelines2 suggesting that risk stratification using the HEAR score be used after possible myocardial infarction has been diagnosed or excluded.
Source: The American Journal of Medicine - Category: General Medicine Authors: Tags: Letter Source Type: research